0000927066-24-000025.txt : 20240223
0000927066-24-000025.hdr.sgml : 20240223
20240223174401
ACCESSION NUMBER: 0000927066-24-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waters Kathleen Alyce
CENTRAL INDEX KEY: 0001640409
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 24672874
MAIL ADDRESS:
STREET 1: C/O DAVITA INC.
STREET 2: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
4
1
wk-form4_1708728222.xml
FORM 4
X0508
4
2024-02-21
0
0000927066
DAVITA INC.
DVA
0001640409
Waters Kathleen Alyce
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
0
1
0
0
Chief Legal & Pub. Affairs Off
0
Common Stock
2024-02-21
4
M
0
40000
52.41
A
121297
D
Common Stock
2024-02-21
4
D
0
17044
123
D
104253
D
Common Stock
2024-02-21
4
F
0
11671
123
D
92582
D
Common Stock
2024-02-21
4
S
0
11285
120.73
D
81297
D
Stock Appreciation Rights
52.41
2024-02-21
4
M
0
40000
0
D
2022-06-20
2024-06-20
Common Stock
40000
0
D
Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
Represents the weighted average sale price of $120.73. The range of prices for the sale of these shares was $120.09 - $122.02 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023.
/s/ Stephanie N. Berberich, Attorney-in-Fact
2024-02-23